Correlation Between Monopar Therapeutics and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Phibro Animal Health, you can compare the effects of market volatilities on Monopar Therapeutics and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Phibro Animal.

Diversification Opportunities for Monopar Therapeutics and Phibro Animal

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Monopar and Phibro is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Phibro Animal go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Phibro Animal

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 2.3 times more return on investment than Phibro Animal. However, Monopar Therapeutics is 2.3 times more volatile than Phibro Animal Health. It trades about 0.33 of its potential returns per unit of risk. Phibro Animal Health is currently generating about 0.01 per unit of risk. If you would invest  1,467  in Monopar Therapeutics on August 31, 2024 and sell it today you would earn a total of  603.00  from holding Monopar Therapeutics or generate 41.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  Phibro Animal Health

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Phibro Animal Health 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point.

Monopar Therapeutics and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and Phibro Animal

The main advantage of trading using opposite Monopar Therapeutics and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind Monopar Therapeutics and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets